Craft

Aurisco Pharmaceutical

Stock Price

¥22.9

2024-10-29

Market Capitalization

¥9.1 B

2024-10-29

Revenue

¥1.7 B

FY, 2025

Aurisco Pharmaceutical Summary

Company Summary

Overview
Aurisco Pharmaceutical (澳瑞科藥業有限公司) is a pharmaceutical company engaged in the research, manufacturing, and marketing of active pharmaceutical ingredients (APIs). Its products include bempedoic acid, apalutamide, abiiraterone acetate, semaglutide, etc.
Type
Public
Status
Active
Founded
1998
HQ
Shanghai, CN | view all locations
Website
http://www.aurisco.com
Cybersecurity rating
Sectors

Key People

  • Alessandro Ricci, President and Business Development Director, New York

  • Zhien Peng

LocationsView all

1 location detected

  • Shanghai, Shang Hai Shi HQ

    China

    17th floor, Hitech Plaza, 488 S. Wuning Road

Aurisco Pharmaceutical Financials

Summary Financials

Revenue (Q1, 2026)
¥386.5M
Gross profit (Q1, 2026)
¥205.0M
Net income (Q1, 2026)
¥63.9M
Cash (Q1, 2026)
¥688.9M
EBIT (Q1, 2026)
¥94.3M
Enterprise value
$9.5B

Footer menu